Zobrazeno 1 - 10
of 863
pro vyhledávání: '"G.H. Schmidt"'
Autor:
Yulu Wang, Jiading Qin, Amit Sharma, Tikam Chand Dakal, Jieyu Wang, Tiantian Pan, Ravi Bhushan, Peng Chen, Maria F. Setiawan, Ingo G.H. Schmidt-wolf, Fei Li
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract RGS (Regulator of G protein signaling) proteins have long captured the fascination of researchers due to their intricate involvement across a wide array of signaling pathways within cellular systems. Their diverse and nuanced functions have
Externí odkaz:
https://doaj.org/article/aeae2af397144ee6810256fe02c2658a
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-15 (2024)
Abstract Undeniably, cancer immunotherapies have expanded the spectrum of cancer treatment, however, some patients do not respond to immunotherapies. This scenario is no different for lung cancer, whose two main types, non-small cell lung cancer (NSC
Externí odkaz:
https://doaj.org/article/69bfd3fa7c6a4ad7981fd82e32a8349f
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-18 (2024)
Abstract A firm link between endoplasmic reticulum (ER) stress and tumors has been wildly reported. Endoplasmic reticulum oxidoreductase 1 alpha (ERO1α), an ER-resident thiol oxidoreductase, is confirmed to be highly upregulated in various cancer ty
Externí odkaz:
https://doaj.org/article/500a17bba7f641ce9780392d3808f1fd
Autor:
Maximilian Merz, Anna Jauch, Thomas Hielscher, Tilmann Bochtler, Stefan Olaf Schönland, Anja Seckinger, Dirk Hose, Uta Bertsch, Kai Neben, Marc Steffen Raab, Jens Hillengass, Hans Salwender, Igor Wolfgang Blau, Hans-Walter Lindemann, Ingo G.H. Schmidt-Wolf, Christof Scheid, Mathias Haenel, Katja C. Weisel, Hartmut Goldschmidt
Publikováno v:
Blood Advances, Vol 2, Iss 1, Pp 1-9 (2018)
Abstract: We investigated subclonal cytogenetic aberrations (CA) detected by interphase fluorescence in situ hybridization (iFISH) in patients with newly diagnosed multiple myeloma (MM) enrolled in the Haemato Oncology Foundation for Adults in the Ne
Externí odkaz:
https://doaj.org/article/caffb444f7f64cd6be641ae199cb164e
Autor:
Artur Słomka, Bingduo Wang, Tudor Mocan, Adelina Horhat, Arnulf G. Willms, Ingo G.H. Schmidt-Wolf, Christian P. Strassburg, Maria A. Gonzalez-Carmona, Veronika Lukacs-Kornek, Miroslaw T. Kornek
Publikováno v:
Theranostics. 12:5836-5855
Liquid biopsies do promise a lot, but are they keeping it? In the past decade, additional novel biomarkers qualified to be called like that, of which, some took necessary hurdles resulting in FDA approval and clinical use. Some others are since a whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d8cd65e718bba1f6fb28adf93d8ec56
https://doi.org/10.7150/thno.73400
https://doi.org/10.7150/thno.73400
Autor:
Ingo G.H. Schmidt-Wolf, Alexander Pröbstl, Diana Henschel, Jörg C. Kalff, Christiane Kloeß, Marie Harnischmacher, Martin W. von Websky, Regina Heuser, Annekristin Hausen, Christian P. Strassburg
Publikováno v:
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie. 146:283-295
Zusammenfassung Hintergrund Mangelernährung bei hospitalisierten Patienten ist ein relevantes Problem unterschätzten Ausmaßes mit negativen Auswirkungen auf das Überleben und den Behandlungserfolg bei einer Vielzahl von chirurgischen Krankheitsbi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dccc285f7c27c3988362f472d7f9eadb
https://doi.org/10.1055/a-1481-9227
https://doi.org/10.1055/a-1481-9227
Autor:
Thomas Kowalski, Alexander Baraniskin, Ulrich Herrlinger, Michelle Margold, Uwe Schlegel, Sabine Seidel, Anna Verena Frey, Agnieszka Korfel, Roland Schroers, Swetlana Ladigan, Ingo G.H. Schmidt-Wolf
Publikováno v:
Neuro-Oncology
Neuro Oncol
Neuro Oncol
Background In patients with presumed primary CNS lymphoma (PCNSL), a systemic manifestation is found only in a small minority. Although bone marrow biopsy (BMB) is recommended for staging, its diagnostic value is unclear. Methods A retrospective anal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a423f4ff4ff16a46b004ca3e73e33056
http://europepmc.org/articles/PMC8643483
http://europepmc.org/articles/PMC8643483
Autor:
Marie-Luise Hütter-Krönke, Axel Benner, Konstanze Döhner, Jürgen Krauter, Daniela Weber, Margit Moessner, Claus-Henning Köhne, Heinz A. Horst, Ingo G.H. Schmidt-Wolf, Mathias Rummel, Katharina Götze, Elisabeth Koller, Andreas L. Petzer, Hans Salwender, Walter Fiedler, Heinz Kirchen, Detlef Haase, Stephan Kremers, Matthias Theobald, Axel C. Matzdorff, Arnold Ganser, Hartmut Döhner, Richard F. Schlenk
Publikováno v:
Haematologica, Vol 101, Iss 7 (2016)
Outcome of patients with primary refractory acute myeloid leukemia remains unsatisfactory. We conducted a prospective phase II clinical trial with gemtuzumab ozogamicin (3 mg/m2 intravenously on day 1), all-trans retinoic acid (45 mg/m2 orally on day
Externí odkaz:
https://doaj.org/article/e94817aacaec41859b402566beb720a7
Autor:
Daniel A. Wirtz, Corinna Vucur, Matthias Zipfel, Ingo G.H. Schmidt-Wolf, Leonie Weinhold, Matthias Schmid, Ulrich Jaehde
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:1439-1446
Background Head and neck cancer (HNC) patients are particularly vulnerable to drug-related problems (DRPs) given the toxicity of concomitant chemoradiotherapy (CCRT). Objective To investigate the number and type of potential DRPs (pDRPs) in HNC outpa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d720c6b485c2c8c9c736b5c370f45a9f
https://doi.org/10.1177/1078155220962178
https://doi.org/10.1177/1078155220962178
Autor:
Heinz Reichmann, Gabriele Schackert, Ingo G.H. Schmidt-Wolf, Frank Kroschinsky, Annika Kowoll, Klaus Fliessbach, Marlies Vogt-Schaden, Thomas Klockgether, Andreas Engert, Gerlinde Egerer, Sabine Schlömer, Udo Bode, Uwe Schlegel, Sabine Seidel, Martina Deckert, Ulrich Herrlinger, Hendrik Pels, Rolf Fimmers
Publikováno v:
Neurology
article-version (Version of Record) 3
article-version (Version of Record) 3
ObjectiveTo determine whether a fraction of patients with primary CNS lymphoma (PCNSL) had been cured by systemic and intraventricular methotrexate- and cytarabine-based chemotherapy (Bonn protocol) after a very long-term follow-up of nearly 20 years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2d9a3899c95fd3137753dca087bfb75
https://doi.org/10.1212/wnl.0000000000010949
https://doi.org/10.1212/wnl.0000000000010949